The digital edge: examining the relationship between digital competency and language learning outcomes

por Cao, Jiafan, Bhuvaneswari, G., Arumugam, Thangaraja, Aravind, B. R.
Publicado 2023

Antitumor and Immunopotentiating Activity of Polysaccharide PST001 Isolated from the Seed Kernel of Tamarindus indica: An In Vivo Study in Mice

por Aravind, S. R., Joseph, Manu M., Varghese, Sheeja, Balaram, Prabha, Sreelekha, T. T.
Publicado 2012

Remogliflozin Etabonate in the Treatment of Type 2 Diabetes: Design, Development, and Place in Therapy

por Mohan, Viswanathan, Mithal, Ambrish, Joshi, Shashank R, Aravind, S R, Chowdhury, Subhankar
Publicado 2020

Pharmacokinetic Similarity between Biosimilar Insulin Aspart Premix SAR341402 Mix 70/30 and Originator Insulin Aspart Mix 70/30 (NovoMix 30) in Indian Adults with Type 2 Diabetes:...

por Mohan, Viswanathan, Schmider, Wolfgang, Singh, Kiran P., Rotthaeuser, Baerbel, Mukherjee, Bhaswati, Aravind, S. R.
Publicado 2022

Co-Encapsulation of Doxorubicin With Galactoxyloglucan Nanoparticles for Intracellular Tumor-Targeted Delivery in Murine Ascites and Solid Tumors

por Joseph, Manu M., Aravind, S.R., George, Suraj K., Pillai, Raveendran K., Mini, S., Sreelekha, T.T.
Publicado 2014

Pseudopyronine B: A Potent Antimicrobial and Anticancer Molecule Isolated from a Pseudomonas mosselii

por Nishanth Kumar, S., Aravind, S. R., Jacob, Jubi, Gopinath, Geethu, Lankalapalli, Ravi S., Sreelekha, T.T., Dileep Kumar, B.S.
Publicado 2016

Blood glucose levels should be considered as a new vital sign indicative of prognosis during hospitalization

por Kesavadev, Jothydev, Misra, Anoop, Saboo, Banshi, Aravind, S.R., Hussain, Akhtar, Czupryniak, Leszek, Raz, Itamar
Publicado 2021

Role of AXL in invasion and drug resistance of colon and breast cancer cells and its association with p53 alterations

por Abdel-Rahman, Wael M, Al-khayyal, Noura A, Nair, Vidhya A, Aravind, S R, Saber-Ayad, Maha
Publicado 2017

Efficacy, Safety, and Immunogenicity of Biosimilar Insulin Aspart Premix SAR341402 Mix 70/30 Compared with Originator Insulin Aspart Mix 70/30 in Adults with Diabetes (GEMELLI M):...

por Aravind, S. R., Singh, Kiran P., Mogylnytska, Liliia, Zalevskaya, Alsu G., Matyjaszek-Matuszek, Beata, Wernicke-Panten, Karin, Nguyên-Pascal, My-Liên, Pierre, Suzanne, Rotthaeuser, Baerbel, Kramer, Daniel, Mukherjee, Bhaswati
Publicado 2022

Biosimilar Insulin Aspart Premix SAR341402 Mix 70/30 Versus Originator Insulin Aspart Mix 70/30 (NovoMix 30) in People with Diabetes: A 26-Week, Randomized, Open-Label Trial (GEMEL...

por Aravind, S. R., Singh, Kiran P., Aquitania, Grace, Mogylnytska, Liliia, Zalevskaya, Alsu G., Matyjaszek-Matuszek, Beata, Wernicke-Panten, Karin, Nguyên-Pascal, My-Liên, Pierre, Suzanne, Rotthaeuser, Baerbel, Kramer, Daniel, Mukherjee, Bhaswati
Publicado 2022

Time to reposition sulfonylureas in type 2 diabetes management in Indian context: A pragmatic practical approach

por Das, Ashok Kumar, Saboo, Banshi, Chawla, Rajeev, Aravind, S. R., Rajput, Rajesh, Singh, Awadhesh K., Mukherjee, J. J., Jhingan, Ashok, Shah, Parag, Deshmukh, Vaishali, Kale, Shailaja, Jaggi, Shalini, Sridhar, G. R., Dhediya, Rajnish, Gaurav, Kumar
Publicado 2023

Efficacy and Safety of Remogliflozin Etabonate, a New Sodium Glucose Co-Transporter-2 Inhibitor, in Patients with Type 2 Diabetes Mellitus: A 24-Week, Randomized, Double-Blind, Act...

por Dharmalingam, Mala, Aravind, S. R., Thacker, Hemant, Paramesh, S., Mohan, Brij, Chawla, Manoj, Asirvatham, Arthur, Goyal, Ramesh, Shembalkar, Jayashri, Balamurugan, R., Kadam, Pradnya, Alva, Hansraj, Kodgule, Rahul, Tandon, Monika, Vaidyanathan, Sivakumar, Pendse, Amol, Gaikwad, Rajesh, Katare, Sagar, Suryawanshi, Sachin, Barkate, Hanmant
Publicado 2020